Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.45
Delayed Data
As of 4:01pm ET
 -0.09 / -5.84%
Today’s Change
1.37
Today|||52-Week Range
8.47
-37.77%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 19.00 and a low estimate of 10.00. The median estimate represents a +968.97% increase from the last price of 1.45.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Aridis Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.53
Sales
$3.6M
Reporting Date
Mar 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 72.55%
 
 
 
 
 
 
Growthannually -51.84%
 
 
 
 
 

Sales

Growthquarterly 599.03%
 
 
 
 
 
Growthannually 132.40%
 
 
 
 
 
Key to the earnings and sales forecast charts.